In January, functional genomics com...
In January, functional genomics company atugen AG (Berlin, Germany) signed a collaboration agreement with pharmaceutical manufacturer Novo Nordisk A/S (Bagsvaerd, Denmark) to validate novel genetic targets associated with diabetes and related diseases. atugen will disentangle GeneBlocs, ...
Bowel Child In Movement , Golf Vacations , Property In Sal , Property For Sale Panama , Music Myspace Layouts |